Journalist Hunt

Resources ▾

Journalist DatabaseFor JournalistsPricing
LoginSign up

Elizabeth Crane - Journalist Profile | Connect with top journalists

View 's journalist industries, journalist types, location, and media outlets. Use Journalist Hunt to get connected with top journalists in seconds.

Get connected with journalists today
Senior Copy Editor, Recode

Elizabeth Crane

Verified

Senior Copy Editor, Recode

San Francisco

Beats

Primary beats

United KingdomFashion

Secondary beats

ShowsPost PunkTo Breaking NewsEmerging DesignersVideo Game IndustryStyleParentingGeneralInterfaith WorkHyperpopCover StoriesJazzAmazôniaEthical Fashion

Biography

Final Covers

Heritage ConservationInternational Relations Social Identity Fiction

Doesn’t Cover

Journalist Type

Copy Editor

Seniority Positions

Senior

Industries

Online Media

Medium Formats

Online,Print

Content

Total articles 36

  • Available on paid plans

    South Korea’s Martial Law Fail: A U.S. President-Elect’s Guide to Getting It Right

    By Elizabeth Crane

    Dec. 07, 2024

  • Available on paid plans

    Solve Vox crosswords in our first-ever puzzle books

    By Elizabeth Crane

    Oct. 17, 2023

  • Available on paid plans

    South Korea’s Martial Law Fail: A U.S. President-Elect’s Guide to Getting It Right

    By Elizabeth Crane

    Dec. 07, 2024

As seen in

Realclear Markets,Audiofile Magazine,The Journal Of Biological Chemistry,Commentary Magazine,Medium,Guernica Mag,The A.V. Club,Electric Literature,Annals Of Internal Medicine,Vox

Company Info

Recode

ReCode Therapeutics is a genetic medicines company based in Dallas, Texas, focused on developing targeted therapies for rare and common genetic diseases, particularly respiratory conditions like primary ciliary dyskinesia (PCD) and cystic fibrosis (CF). The company utilizes its proprietary SORT LNP (Selective ORgan Targeting Lipid Nanoparticle) platform to deliver mRNA and gene correction therapeutics directly to affected organs, addressing significant unmet medical needs. The SORT LNP platform allows for organ-specific delivery, enhancing the effectiveness of treatments by bypassing the liver when necessary. ReCode's pipeline includes mRNA therapies aimed at correcting the underlying genetic causes of PCD and CF, with plans to expand into other areas such as muscular, CNS, liver, infectious diseases, and oncology. The company emphasizes disease-modifying outcomes through its innovative approach to genetic medicine.

San Francisco, California, United States

+1 408-585-1700

Founded: 2014



Journalist Hunt

Email us

contact@journalisthunt.com
Terms and ConditionsRefund PolicyPrivacy Policy

Copywright © 2025, Journalist Hunt. All right reserved